|

Heart Disease Clinical Trials in Connecticut

72 recruiting studies across 16 cities

All Trials in Connecticut

Phase
Trial Phase Location
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Bloomfield
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Bridgeport
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Bridgeport
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography TrialPhase 3Bridgeport
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Bridgeport
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Bridgeport
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence—Brookfield
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Danbury
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Danbury
Assessment of CCM in HF With Higher Ejection FractionN/ADanbury
Product Surveillance Registry—Darien
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure—Farmington
Circulating Markers for Ischemic Heart Disease—Farmington
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease—Farmington
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Greenwich
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Hartford
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—Hartford
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava IsolationN/AHartford
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveN/AHartford
Alleviant ALLAY-HF StudyN/AHartford
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)N/AHartford
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/AHartford
ELEVATE-HFpEF Clinical StudyN/AHartford
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Hartford
FORWARD CAD IDE StudyN/AHartford
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Hartford
Left vs Left Randomized Clinical TrialN/AHartford
Medtronic Terminate AF StudyN/AHartford
PARTNER 3 Trial - Aortic Valve-in-ValveN/AHartford
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmN/AHartford
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive ProcedureN/AHartford
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Hartford
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Hartford
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/AHartford
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Middletown
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3New Haven
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart DiseaseN/ANew Haven
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac EventsPhase 2New Haven
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3New Haven
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart FailureN/ANew Haven
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/ANew Haven
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3New Haven
Cardiac Sarcoidosis Randomized TrialPhase 3New Haven
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—New Haven
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/ANew Haven
Ertugliflozin in Chronic Heart FailurePhase 2New Haven
Exploring Water-free Sodium StorageN/ANew Haven
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3New Haven
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/ANew Haven
Identification of Brain Injury Using Portable MRI—New Haven
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart FailureN/ANew Haven
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic ConditionsPhase 4New Haven
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPhase 3New Haven
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)Phase 3New Haven
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/ANew Haven
Mechanisms of Diuretic Resistance in Heart Failure, Aim 1Phase 1New Haven
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2Phase 1New Haven
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3Phase 1New Haven
Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst—New Haven
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/ANew Haven
Promoting Palliative Care for People With Heart FailureN/ANew Haven
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System—New Haven
Simulation Trial of Telemedical Support for ParamedicsN/ANew Haven
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal SyndromePhase 2New Haven
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)N/ANew Haven
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid RegurgitationN/ANew Haven
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyPhase 3Norwich
Healing Hearts: A Mindfulness App for Parents Navigating Divorce or SeparationN/AStamford
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Stamford
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Stamford
A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionPhase 2Waterbury
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4West Haven

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.